Host microbiome in tuberculosis: disease, treatment, and immunity perspectives
A Pant, B Das, GA Arimbasseri - Frontiers in Microbiology, 2023 - frontiersin.org
Tuberculosis (TB), an airborne pulmonary disease caused by Mycobacterium tuberculosis
(M. tb), poses an unprecedented health and economic burden to most of the developing …
(M. tb), poses an unprecedented health and economic burden to most of the developing …
[PDF][PDF] An overview of tuberculosis treatments and diagnostics. What role could metabolomics play
I Olivier, DT Loots - Journal of Cell and Tissue Research, 2011 - researchgate.net
In 2001, the WHO declared TB a global emergency, as one third of the worlds population
suffered from latent M. tuberculosis infection. Today, a decade later, millions of people still …
suffered from latent M. tuberculosis infection. Today, a decade later, millions of people still …
Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials [State of the art series. Operational research. Number 4 in the series]
DJ Bratton, AJ Nunn - The International Journal of Tuberculosis …, 2011 - ingentaconnect.com
Clinical trials are sometimes classified as being explanatory or pragmatic, although they are
rarely reported in that way. Explanatory trials may seek to investigate the efficacy of new …
rarely reported in that way. Explanatory trials may seek to investigate the efficacy of new …
In silico evaluation and exploration of antibiotic tuberculosis treatment regimens
Background Improvement in tuberculosis treatment regimens requires selection of
antibiotics and dosing schedules from a large design space of possibilities. Incomplete …
antibiotics and dosing schedules from a large design space of possibilities. Incomplete …
Defining outcomes of tuberculosis (treatment): from the past to the future
G Günther, J Heyckendorf, JP Zellweger, M Reimann… - Respiration, 2021 - karger.com
Untreated active tuberculosis (TB) has a very high long-term mortality. Treatment of TB
reduces mortality dramatically and should maximize cure, preventing ongoing transmission …
reduces mortality dramatically and should maximize cure, preventing ongoing transmission …
Microbiome-immune interactions in tuberculosis
Tuberculosis (TB) remains an infectious disease of global significance and a leading cause
of death in low-and middle-income countries. Significant effort has been directed towards …
of death in low-and middle-income countries. Significant effort has been directed towards …
Can systems immunology lead tuberculosis eradication?
Abstract 25 years after the declaration of a Global Emergency by the World Health
Organization, tuberculosis (TB) remains a major enemy to the humankind. During this …
Organization, tuberculosis (TB) remains a major enemy to the humankind. During this …
[HTML][HTML] Systems proteomics approaches to study bacterial pathogens: application to Mycobacterium tuberculosis
A Banaei-Esfahani, C Nicod, R Aebersold… - Current opinion in …, 2017 - Elsevier
Highlights•Genomic and transcriptional analyses have paved the way to study
Mycobacterium tuberculosis (Mtb) at a molecular level.•Shotgun-MS, S/MRM and …
Mycobacterium tuberculosis (Mtb) at a molecular level.•Shotgun-MS, S/MRM and …
TB Summit 2014: prevention, diagnosis, and treatment of tuberculosis—a meeting report of a Euroscicon conference
World TB Day commemorates Dr Robert Koch's first announcement on March 24, 1882, that
the bacterium Mycobacterium tuberculosis is the causative agent of tuberculosis. Currently …
the bacterium Mycobacterium tuberculosis is the causative agent of tuberculosis. Currently …
[PDF][PDF] Tuberculosis handbook
A Pio, P Chaulet - 1998 - apps.who.int
Objectives The handbook's ultimate objective is to help ensure that local, national and
institutional TB control programmes are efficiently organized and effective in decreasing the …
institutional TB control programmes are efficiently organized and effective in decreasing the …